Brought to you by 
China Medical nets $233mm through sale of senior notes
14 Aug 2008
Executive Summary
In a public offering that was initially slated for $150mm, China Medical Technologies (FISH diagnostics and high-intensity focused ultrasound) netted $233mm through the sale of $240mm aggregate amount of its 4% senior notes that are due in 2013. The notes convert into ADSs at $58.80. (The company's ADSs were trading at $49.66 at the time of the sale.) China Medical also announced that it will enter into ADS issuance and repurchase agreements with underwriter affiliates, selling up to 4.7mm ADSs, for which China Medical will not receive any proceeds.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Diagnostic Imaging Equipment & Supplies
- Ultrasound
-
Surgical Equipment & Devices
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
China Medical nets $233mm through sale of senior notes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice